Work

Inclusion of a recovery period after pulse treatment in the primary human lymphocyte micronucleus assay covers potential cell cycle delays without loss of sensitivity

Year: 2026

Type: article

Source: Mutagenesis

DOI: 10.1093/mutage/geag013

Authors: Alina Goepfert, Miriam Spies, Natascha Partosa, Silke Spang, James Whitwell, Robert Smith, Abigail Lamb, Christine Marchand, Andreas Zeller, Jasmin Lott, Kristina Trenz, Azeddine Elhajouji, Hans-Joerg Martus, Murielle Brichet, Martin Schneider, Steffen Naumann, Markus Schulz, Jessica Dieckhoff, Naveed Honarvar, Robert Landsiedel

Institutions: BASF (Germany), Freie Universität Berlin, Technische Hochschule Mannheim, Roche (Switzerland), Boehringer Ingelheim (Germany), Novartis (Switzerland), Merck Healthcare KGaA, Darmstadt (Germany)

Language: English

Topic: Carcinogens and Genotoxicity Assessment

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7134280938

FWCI:

Cites: 34

Cited by:

Related to: